Hyperfine (HYPR) Operating Income Growth (3y) (2024 - 2026)
Hyperfine (HYPR) Operating Income Growth (3y) (2024 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Op. Inc Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.07 Bn | 193.46 Bn | 7.27 Bn | 3.16% |
| 2 | Stryker | 127.90 Bn | 124.43 Bn | 4.50 Bn | 19.80% |
| 3 | Medtronic | 118.84 Bn | 109.62 Bn | 6.41 Bn | 6.17% |
| 4 | Boston Scientific | 73.33 Bn | 72.79 Bn | 3.85 Bn | 31.84% |
| 5 | Edwards Lifesciences | 51.93 Bn | 47.68 Bn | 1.35 Bn | 24.88% |
| 6 | Dexcom | 34.46 Bn | 32.51 Bn | 830.00 Mn | 35.44% |
| 7 | GE HealthCare Technologies | 33.91 Bn | 31.81 Bn | 2.18 Bn | 9.04% |
| 8 | Koninklijke Philips | 26.36 Bn | 23.04 Bn | 4.55 Bn | 60.19% |
| 9 | Steris | 23.12 Bn | 22.64 Bn | 684.20 Mn | 13.06% |
| 10 | Hyperfine | 89.22 Mn | 44.45 Mn | 1.98 Mn | 10.19% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 10.19% |
| Mar 31, 2026 | 13.09% |
| Dec 31, 2025 | 17.45% |
| Sep 30, 2025 | 12.43% |
| Jun 30, 2025 | 25.49% |
| Mar 31, 2025 | 22.88% |
| Dec 31, 2024 | 25.55% |
| Sep 30, 2024 | 12.55% |
| Jun 30, 2024 | 9.40% |
| Mar 31, 2024 | -10.92% |